SITC 2021 Registration Now Open Participate in person or virtually at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) taking place Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Click here for more information about registering for SITC 2021.
Download the new SITC Clinical Practice Guidelines (CPG) Mobile App! The first and only immunotherapy-specific clinical practice guidelines app featuring guideline content and expert panel recommendations in an easy-to-navigate format. The app includes interactive tools, bookmarks, and advanced search capabilities.Available for FREE for iOS and Android.
New SITC Clinical Practice Guidelines Published
JITC Increases Impact Factor to 13.751The Journal for ImmunoTherapy of Cancer's (JITC) Impact Factor makes JITC the highest ranked fully open access immunology journal and places it in the top 5% percent of all journals published in the category of immunology and top 7% in the category of oncology.
SITC is pleased to announce the reinvigoration of the society’s innovative program designed to foster leadership development, collaborations and scientific exchange among early career investigators who are emerging leaders in the field of cancer immunotherapy: Sparkathon Accelerator: Emerging Leaders Igniting Innovation.
Apply to attend SITC’s new Clinical Immuno-Oncology Network (SCION) Workshop, taking place Jan. 23–28, 2022, in Austin, Texas. Selected participants will develop a full cancer immunotherapy clinical trial protocol through small-group work with guidance from expert faculty during the five-day program. Applications are due Sept. 10 by 5 p.m. PDT.
A series of eight two-hour online seminars will feature experts in a given subject area to provide an overview of the current scientific knowledge about an area of immunotherapy. An interactive Q&A session will follow the topic overview, providing attendees the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.
Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Virtual Workshop, Sept. 29–30, 2021. This SITC workshop will focus on the tumor cell surfaceome and the many opportunities that accompany it for the development of future immunotherapies and the maximization of existing techniques.
Attend SITC's Bispecific T cell Engagers Virtual Workshop, Sept. 30–Oct. 1, 2021. This SITC workshop will focus on T cell engager biology and therapeutic strategies including target selection, therapeutic engineering and design features, cytotoxicity vs cytokine release, the impact of the tumor microenvironment, and advances in conditionally-active binding.
Comprised of several authoritative reviews of COVID-19 and Cancer Immunotherapy, this series, edited by Paolo Antonio Ascierto, MD and Jason D. Goldman, MD, MPH, will explore basic insights into the immunology of the novel coronavirus, repurposing of immune-based therapies including the effects of immune-oncology agents, and the affected cancer populations.
Attend SITC's Cytokines in Cancer Immunotherapy Virtual Workshop, Oct. 11–12, 2021. This SITC workshop will focus on providing a deeper understanding of cytokines in immune cell proliferation, differentiation, and function, as they pertain to tumor immunobiology and cancer immunotherapy approaches. Submit your research by 5 p.m. PDT on Sept. 3.
Join Alan Hutson, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
New Online Patient Course Available: Understanding Cancer Immunotherapy Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in tumor immunology and cancer immunotherapy.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Good information. ------------------------------ Six Clicks 6clicks ------------------------------
This complimentary program brings Africa and the world together to develop the liver cancer diagnosis, prevention and treatment guidelines to help improve outcomes for all liver cancer patients in Africa. Register online at: www.mskcc.org/AfricaLiverGuidelines ...
I want to welcome every and each of you to this community. The aim is to bring together people with the passion for early phase trials. If you are involved or curious about these trials, you know how special these trials are. So, my hope is that thorough ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org